Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 10.15.2018
The Joint Science and Technology Office (JSTO) Science Review (JSR) fosters collaboration, cooperation and innovation by allowing program managers and senior leadership to understand the latest warfighter-driven technologies in development....
Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 10.15.2018
DNA-based nucleic acid vaccines have the potential to become a universal platform solution to viral threat agents. The U.S. Department of Defense is currently developing DNA vaccines to protect against a variety of viral threats including alphaviruses, filoviruses and hantaviruses....
Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 10.15.2018
When Ebola virus disease (EVD) reared its head in May in the Congo, the world was armed with the rVSV-ZEBOV vaccine thanks to interagency collaboration efforts by the Defense Threat Reduction Agency’s Chemical and Biological Technologies Department....
Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 10.24.2017
Share innovative ideas with more than 1,500 of the most influential scientists, program managers and leaders in the defense community at the 2017 Chemical and Biological Defense Science & Technology (CBD S&T) Conference Nov. 28-30, 2017, in Long Beach, Calif....
Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 01.10.2017
The rising tide of antimicrobial resistance (AMR), or the ability of a microbe to resist the effects of medication previously used to treat them, is a growing threat to both public health and the warfighter. The World Health Organization listed AMR as one of today’s biggest threats to global health, food security and development....
